394 related articles for article (PubMed ID: 12451112)
1. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Monfort P; Muñoz MD; Felipo V
Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
Monfort P; Muñoz MD; Felipo V
Metab Brain Dis; 2005 Dec; 20(4):265-74. PubMed ID: 16382337
[TBL] [Abstract][Full Text] [Related]
5. Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long-term depression, but not long-term potentiation, in the dentate gyrus in vitro.
Wu J; Wang Y; Rowan MJ; Anwyl R
J Neurosci; 1998 May; 18(10):3589-96. PubMed ID: 9570790
[TBL] [Abstract][Full Text] [Related]
6. On the role of nitric oxide in hippocampal long-term potentiation.
Bon CL; Garthwaite J
J Neurosci; 2003 Mar; 23(5):1941-8. PubMed ID: 12629199
[TBL] [Abstract][Full Text] [Related]
7. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
Monfort P; Felipo V
BMC Pharmacol; 2005 Jun; 5 Suppl 1(Suppl 1):P66. PubMed ID: 15969770
[No Abstract] [Full Text] [Related]
8. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
Monfort P; Muñoz MD; Felipo V
J Neurochem; 2005 Aug; 94(4):934-42. PubMed ID: 16092938
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation.
Centonze D; Pisani A; Bonsi P; Giacomini P; Bernardi G; Calabresi P
J Neurosci; 2001 Feb; 21(4):1393-400. PubMed ID: 11160411
[TBL] [Abstract][Full Text] [Related]
10. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
Bon CL; Garthwaite J
Eur J Neurosci; 2001 Aug; 14(4):585-94. PubMed ID: 11556884
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
12. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
13. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
[TBL] [Abstract][Full Text] [Related]
14. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway.
Petr J; Rajmon R; Chmelíková E; Tománek M; Lánská V; Pribánová M; Jílek F
Zygote; 2006 Feb; 14(1):9-16. PubMed ID: 16700970
[TBL] [Abstract][Full Text] [Related]
15. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP⁺ cytotoxicity.
Kurauchi Y; Hisatsune A; Isohama Y; Sawa T; Akaike T; Katsuki H
Neuroscience; 2013 Feb; 231():206-15. PubMed ID: 23238575
[TBL] [Abstract][Full Text] [Related]
17. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
[TBL] [Abstract][Full Text] [Related]
18. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
[TBL] [Abstract][Full Text] [Related]
19. Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation.
Jernigan NL; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1366-75. PubMed ID: 12003794
[TBL] [Abstract][Full Text] [Related]
20. Modulation of soluble guanylate cyclase activity by phosphorylation.
Murthy KS
Neurochem Int; 2004 Nov; 45(6):845-51. PubMed ID: 15312978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
